PortfoliosLab logoPortfoliosLab logo
NEON vs. CDNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NEON vs. CDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neonode Inc. (NEON) and CareDx, Inc (CDNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NEON achieves a 4.60% return, which is significantly lower than CDNA's 18.42% return. Over the past 10 years, NEON has underperformed CDNA with an annualized return of -20.16%, while CDNA has yielded a comparatively higher 17.18% annualized return.


NEON

1D
10.98%
1M
9.64%
YTD
4.60%
6M
-21.89%
1Y
-82.42%
3Y*
-39.91%
5Y*
-21.46%
10Y*
-20.16%

CDNA

1D
1.09%
1M
6.44%
YTD
18.42%
6M
18.36%
1Y
27.92%
3Y*
40.00%
5Y*
-22.72%
10Y*
17.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NEON vs. CDNA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NEON
Neonode Inc.
4.60%-78.86%259.39%-58.36%-37.85%31.11%247.94%16.87%-77.66%-59.61%
CDNA
CareDx, Inc
18.42%-12.00%78.42%5.17%-74.91%-37.23%235.88%-14.20%242.51%171.85%

Correlation

The correlation between NEON and CDNA is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Jul 18, 2014

0.13

The correlation between NEON and CDNA shifts across timeframes, from 0.13 (all time) to 0.26 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NEON:

$30.55M

CDNA:

$1.19B

EPS

NEON:

$0.50

CDNA:

-$0.15

PS Ratio

NEON:

14.12

CDNA:

2.87

PB Ratio

NEON:

1.34

CDNA:

3.78

Total Revenue (TTM)

NEON:

$2.16M

CDNA:

$412.82M

Gross Profit (TTM)

NEON:

$1.81M

CDNA:

$198.97M

EBITDA (TTM)

NEON:

$7.89M

CDNA:

$4.15M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEON vs. CDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEON
NEON Risk / Return Rank: 1313
Overall Rank
NEON Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
NEON Sortino Ratio Rank: 1313
Sortino Ratio Rank
NEON Omega Ratio Rank: 1010
Omega Ratio Rank
NEON Calmar Ratio Rank: 88
Calmar Ratio Rank
NEON Martin Ratio Rank: 2020
Martin Ratio Rank

CDNA
CDNA Risk / Return Rank: 5656
Overall Rank
CDNA Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
CDNA Sortino Ratio Rank: 5555
Sortino Ratio Rank
CDNA Omega Ratio Rank: 5959
Omega Ratio Rank
CDNA Calmar Ratio Rank: 5555
Calmar Ratio Rank
CDNA Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEON vs. CDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neonode Inc. (NEON) and CareDx, Inc (CDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NEONCDNADifference

Sharpe ratio

Return per unit of total volatility

-0.67

0.39

-1.06

Sortino ratio

Return per unit of downside risk

-0.85

1.03

-1.87

Omega ratio

Gain probability vs. loss probability

0.86

1.16

-0.30

Calmar ratio

Return relative to maximum drawdown

-0.86

0.64

-1.50

Martin ratio

Return relative to average drawdown

-1.03

1.32

-2.35

NEON vs. CDNA - Sharpe Ratio Comparison

The current NEON Sharpe Ratio is -0.67, which is lower than the CDNA Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of NEON and CDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NEONCDNADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.67

0.39

-1.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.20

-0.30

+0.09

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.20

0.22

-0.42

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.22

0.10

-0.32

Drawdowns

NEON vs. CDNA - Drawdown Comparison

The maximum NEON drawdown since its inception was -99.93%, which is greater than CDNA's maximum drawdown of -94.87%. Use the drawdown chart below to compare losses from any high point for NEON and CDNA.


Loading charts...

Drawdown Indicators


NEONCDNADifference

Max Drawdown

Largest peak-to-trough decline

-99.93%

-94.87%

-5.06%

Max Drawdown (1Y)

Largest decline over 1 year

-95.67%

-43.92%

-51.75%

Max Drawdown (3Y)

Largest decline over 3 years

-95.67%

-65.96%

-29.71%

Max Drawdown (5Y)

Largest decline over 5 years

-95.67%

-94.85%

-0.82%

Max Drawdown (10Y)

Largest decline over 10 years

-95.67%

-94.87%

-0.80%

Current Drawdown

Current decline from peak

-99.89%

-76.66%

-23.23%

Average Drawdown

Average peak-to-trough decline

-96.77%

-53.68%

-43.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

80.08%

21.13%

+58.95%

Volatility

NEON vs. CDNA - Volatility Comparison

Neonode Inc. (NEON) has a higher volatility of 25.36% compared to CareDx, Inc (CDNA) at 9.22%. This indicates that NEON's price experiences larger fluctuations and is considered to be riskier than CDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NEONCDNADifference

Volatility (1M)

Calculated over the trailing 1-month period

25.36%

9.22%

+16.14%

Volatility (6M)

Calculated over the trailing 6-month period

43.84%

44.79%

-0.95%

Volatility (1Y)

Calculated over the trailing 1-year period

123.49%

71.89%

+51.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

107.66%

77.33%

+30.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

98.89%

78.46%

+20.43%

Dividends

NEON vs. CDNA - Dividend Comparison

Neither NEON nor CDNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NEON vs. CDNA - Financials Comparison

This section allows you to compare key financial metrics between Neonode Inc. and CareDx, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00M20222023202420252026
614.00K
117.70M
(NEON) Total Revenue
(CDNA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NEON and CDNA have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NEON has higher volatility (25.36%) compared to CDNA (9.22%). In terms of maximum drawdown, NEON dropped -99.93% vs CDNA's -94.87%.

CDNA currently has the higher Sharpe Ratio (0.39 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NEON and CDNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer